|
Match
|
Document |
Document Title |
|
|
US20140371134 |
Dry Pharmaceutical Compositions for Topical Delivery of Oral Medications, Nasal Delivery and to Treat Ear
In one aspect, a dry formulation for the effective administration of multiple medications simultaneously for one or more ailments may be provided. The dry formulations include one or more of the... |
|
|
US20130035304 |
SMALL MOLECULES FOR THE MODULATION OF MCL-1 AND METHODS OF MODULATING CELL DEATH, CELL DIVISION, CELL DIFFERENTIATION AND METHODS OF TREATING DISORDERS
This invention relates to compounds which selectively bind to the survival protein MCL-1 with high affinity and selectivity, pharmaceutical compositions containing such compounds and the use of... |
|
|
US20150148308 |
PEST CONTROL COMPOSITION FOR HARMFUL ARTHROPODS, AND PEST CONTROL METHOD FOR HARMFUL ARTHROPODS
A harmful arthropod control composition comprising a compound represented by the following Formula (1) wherein each symbol represents definitions described in the specification, and one or more... |
|
|
US20140315846 |
ANDROGRAPHIS PANICULATA EXTRACT
An extract of Andrographis paniculata extract containing androgapholide, 14-deoxyandrographolide, 14-deoxy-11,12-dehydroandrographolide, neoandrographolide, polysaccharides, and flavanoids. Also... |
|
|
US20140378405 |
SALIX EXTRACT, ITS USE AND FORMULATIONS CONTAINING IT
The present invention relates to an extract of Salix spp obtainable by fractioning on a resin and to the process for its preparation. The extract of the invention is characterized by an high... |
|
|
US20120270825 |
SALIX EXTRACT, ITS USE AND FORMULATIONS CONTAINING IT
The present invention relates to an extract of Salix spp obtainable by fractioning on a resin and to the process for its preparation. The extract of the invention is characterized by an high... |
|
|
US20130150318 |
COMPOSITION FOR PREVENTING/CONTROLLING HARMFUL ARTHROPODS AND METHOD FOR PREVENTING/CONTROLLING HARMFUL ARTHROPODS
A harmful arthropod control composition comprising flonicamid, fthalide and kasugamycin hydrochloride. |
|
|
US20130045940 |
COMPOSITION COMPRISING AS ACTIVE INGREDIENT L-CARNITINE IN COMBINATION WITH A SOLAR FILTER, FOR THE PREVENTION AND/OR TREATMENT OF PATHOLOGIES OF THE EYE DUE TO ULTRAVIOLET RADIATION
It is described a composition in the form of eye drops or ointment, comprising as active ingredients L-carnitine or a physiologically acceptable salt thereof; and 3-Hydroxykynurenine... |
|
|
US20120178707 |
METHODS FOR TREATING PROSTRATE CONDITIONS
Methods for treating prostate cancer involving the administration of a compound that selectively inhibits pathological production of human vascular endothelial growth factor (VEGF) are described.... |
|
|
US20130150319 |
COMPOSITION FOR PREVENTING/CONTROLLING HARMFUL ARTHROPODS AND METHOD FOR PREVENTING/CONTROLLING HARMFUL ARTHROPODS
A harmful arthropod control composition comprising flonicamid, tricyclazole, and one or more plant disease control compounds selected from the group consisting of flutolanil, pencycuron and... |
|
|
US20150087610 |
Method of Modifying Fertility
The present invention provides methods and compositions for modifying fertility in a male mammalian subject by contacting the subject's testis cells, germ cells or sperm with a sufficient amount... |
|
|
US20120027699 |
SKIN CARE COMPOSITIONS COMPRISING SUBSTITUTED MONOAMINES
Skin care compositions comprising certain substituted monoamines, which are particularly beneficial for skin lightening and achieving evenness of color, especially for face and underarm skin. |
|
|
US20070142392 |
Uses of rifamycins
The invention features methods, compositions, and kits for treating prosthetic joint infections, foreign body infections, infectious arthritis, and osteomyelitis |
|
|
US20110224162 |
SYNTHETIC ANALOGUES OF PHOSPHATIDYL-MYO-INOSITOL MANNOSIDES WITH AN INHIBITORY ACTIVITY OF THE INFLAMMATORY RESPONSE
The present invention relates to novel synthetic analogues of phosphatidyl-myo-inositol mannosides (hereinafter referred to as PIMs) of general formula (I): or a pharmaceutically acceptable salt... |
|
|
US20120202762 |
METHODS OF USE OF GLYCOMIMETICS WITH REPLACEMENTS FOR HEXOSES AND N-ACETYL HEXOSAMINES
Methods are provided for using a compound to treat, for example, endothelial dysfunction including vascular abnormalities. More specifically, methods are described for using an oligosaccharide... |
|
|
US20130123206 |
TREATMENT OF METABOLIC SYNDROME AND INSULIN RESISTANCE WITH CITRUS FLAVANONES
Methods of treating metabolic syndrome and/or insulin resistance including administering a therapeutically effective amount of purified hesperidin, purified hesperetin, or a purified derivative or... |
|
|
US20120015898 |
COMPOUNDS AND METHODS FOR TREATMENT OF SICKLE CELL DISEASE OR COMPLICATIONS ASSOCIATED THEREWITH
Compounds, compositions and methods are provided for treatment of sickle cell disease or a complication associated therewith, or graft versus host disease, in an individual. More specifically, the... |
|
|
US20110245192 |
NEW ACTIVATORS FOR TREATING AND/OR PREVENTING DISEASES OR MEDICAL CONDITIONS WHICH BENEFIT FROM AN INCREASED TRANSPORT OF HYALURONAN ACROSS A LIPID BILAYER
The present invention relates in general to a compound (activator) which is characterized by a formula selected from the following formulas A, B and/or C or a pharmaceutically acceptable salt... |
|
|
US20140011761 |
Modulating Endoplasmic Reticulum Stress in the Treatment of Tuberous Sclerosis
Endoplasmic reticulum stress has been found to be associated with the genetic disease tuberous sclerosis. Tuberous sclerosis is cause by defects in the two genes, TSC1 and TSC2. Agents that... |
|
|
US20110081418 |
TRANSDERMAL ABSORPTION ENHANCER
An object of the present invention is to provide a transdermal absorption enhancer by which various active ingredients are transdermally absorbed. In accordance with a transdermal absorption... |
|
|
US20130102554 |
COMPOSITION FOR TREATMENT OF OBESITY USING WHEAT BRAN EXTRACT OR ACTIVE INGREDIENT ISOLATED THEREFROM
The present invention relates to a composition for treatment of obesity using a wheat bran extract or a tachioside or 9,12,13-trihydroxy-10(E)-octadecenoic acid, an active ingredient isolated... |
|
|
US20130281387 |
Chemosensory Receptor Ligand-Based Therapies
Provided herein are methods for treating conditions associated with a chemosensory receptor, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administering a... |
|
|
US20130052271 |
Compositions and Methods for Treating Pain
The present invention provides compositions and methods for treating pain in mammals. A composition of the invention comprises one or more anti-inflammatory agents and optionally contains one or... |
|
|
US20150025030 |
Hydroxysafflor yellow A sodium and preparation as well as application thereof
A hydroxysafflor yellow A sodium compound as shown in a formula (I) and preparation as well as medicinal application thereof are provided. According to the present invention, the safflower is... |
|
|
US20100197625 |
SYNTHETIC LIPOPHILIC INOSITOL GLYCANS FOR TREATMENT OF CANCER AND GLUCOSE-METABOLISM DISORDERS
The present intervention related to materials and methods for the synthesis of lipophilic inositol glycan compounds, and salts, solvates and physiological functional derivatives thereof, and their... |
|
|
US20140179625 |
SODIUM CHANNEL BLOCKERS
The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers. |
|
|
US20150190531 |
NANOPARTICLE DELIVERY SYSTEM FOR TARGETED ANTI-OBESITY TREATMENT
A magnetic nanoparticles including a TRPV1 agonist, as well as methods of preparation and use, are described herein. A magnetically responsive pharmaceutical can include a core region having a... |
|
|
US20130331350 |
E-SELECTIN ANTAGONISTS
Compounds, compositions and methods are provided for inhibiting in vitro and in vivo processes mediated by E-selectin binding. More specifically, particular glycomimetic compounds are described,... |
|
|
US20060171986 |
Antibiotic coating of implants
An antibiotic coating of implants is described, which is characterized in that the coating comprises at least one saturated, organic, hydrophobic, low molecular matrix former whose melting point... |
|
|
US20140296175 |
COMPOSITION AND METHOD FOR INDUCING EPO-MEDIATED HAEMOGLOBIN EXPRESSION AND MITOCHONDRIAL BIOGENESIS IN NONHAEMATOPOIETIC CELL
A composition for inducing erythropoietin (EPO)-mediated haemoglobin (Hb) expression in a nonhaematopoietic cell of a subject is provided. The composition includes a compound represented by... |
|
|
US20120231097 |
MEDICINAL COMPOSITION AND USAGE
This invention provides a traditional Chinese medicine composition consisting of the extract of no more than five crude drugs, wherein crude drugs include licorice and also include Radix... |
|
|
US20120027700 |
SKIN CARE COMPOSITIONS COMPRISING SUBSTITUTED DIAMINES
Skin care compositions comprising certain substituted diamines, which are particularly beneficial for skin lightening and achieving evenness of color, especially for face and underarm skin. |
|
|
US20140245496 |
COMPOSITIONS AND METHODS FOR THE BIOSYNTHESIS OF VANILLAN OR VANILLIN BETA-D-GLUCOSIDE
Recombinant microorganisms, plants, and plant cells are disclosed that have been engineered to express a mutant AROM polypeptide and/or mutant catechol-O-methyltransferase polypeptide alone or in... |
|
|
US20080206359 |
Day and Night Composition and method for treating Pseudofolliculitis Barbae
An effective formulation for the treatment and prevention of pseudofolliculitis barbae, commonly called razor bumps, and the skin irritation associated with the condition. The treat formulation... |
|
|
US20090324760 |
Hair tonic
The present invention relates to hair tonic compositions containing acteoside of formula (I) as an active ingredient. The hair tonic composition of the invention has an excellent hair-growth... |
|
|
US20140249099 |
CANCER THERAPY
The present application relates to compositions and methods for treating a proliferative disorder by administering to a subject a pharmaceutical composition of a dual kinase inhibitor metabolite.... |
|
|
US20110039796 |
Natural Composition for Anti-Angiogenesis and Anti-Obesity
The combination of gallic acid, ellagic acid, and rubusoside was shown to inhibit angiogenesis by inhibition of pro-angiogenic factors. These three compounds were shown to be absorbed from the... |
|
|
US20100297156 |
ANALOGUES OF PHOSPHATIDYLINOSITOL MANNOSIDES
The invention relates to compounds which are immunomodulatory compounds and, in particular, can induce IL-12 secretion. The invention also relates to compositions containing the compounds,... |
|
|
US20150140120 |
STABILIZED APTAMERS TO PLATELET DERIVED GROWTH FACTOR AND THEIR USE AS ONCOLOGY THERAPEUTICS
Materials and methods are provided for producing and using aptamers useful as oncology therapeutics capable of binding to PDGF, PDGF isoforms, PDGF receptor, VEGF, and VEGF receptor or any... |
|
|
US20120108505 |
THIOPHENES AS GLUCAGON RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS FOR THEIR USE
The present invention relates to compounds of the general formula (I): wherein R1, R2, R3, R5, s, and Z are selected independently of each other and are as defined herein, to compositions... |
|
|
US20110190199 |
Combination Therapy for Tuberculosis
The present invention relates to methods of treating tuberculosis, including multi-drug resistant varieties and latent tuberculosis. More particularly, the present invention relates to a method of... |
|
|
US20060183698 |
Ophthalmic formulations and uses thereof
Provided by the present invention are compositions or formulations suitable for application to a patient's eyes which utilizes a topical ophthalmically-acceptable formulation comprising a... |
|
|
US20060088604 |
Therapeutic ointment for treating dermatological infections and method of using same
A therapeutic ointment that includes (a) a skin protecting agent, (b) an anti-inflammatory agent, and (c) an antibiotic composition, and a method of using the ointment to treat mammals suffering... |
|
|
US20150197538 |
COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
The present invention encompasses compounds and methods for treating urinary tract infections. |
|
|
US20120309701 |
COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
The present invention encompasses compounds and methods for treating urinary tract infections. |
|
|
US20130143832 |
COMPOSITION FOR PREVENTING/CONTROLLING HARMFUL ARTHROPODS AND METHOD FOR PREVENTING/CONTROLLING HARMFUL ARTHROPODS
A harmful arthropod control composition comprising flonicamid, one or more insect growth regulator compounds selected from Group (A), and one or more sheath blight disease control compounds... |
|
|
US20110166091 |
Compositions Containing Piperacillin and Tazobactam Useful for Injection
An aminocarboxylic acid chelating agent, preferably EDTA, or a salt thereof has been found to be useful for inhibiting particulate formation in piperacillin/tazobactam parenteral combinations. The... |
|
|
US20150224088 |
METHODS OF TREATMENT OF ISCHEMIA-INDUCED ANGIOGENESIS AND ARTERIOGENESIS
It has now been discovered that p53 is a potent inhibitor of angiogenesis and arteriogensis. Inhibition of p53 stimulates angiogenesis, arteriogenesis and improves perfusion in limbs. Therefore,... |
|
|
US20070111956 |
Remedy for sarcoidosis and method of treating the same
The present invention provides a remedy for sarcoidosis, one of systemic granulomatous diseases, and a method for treating sarcoidosis. A remedy for sarcoidosis containing a Propionibacterium... |
|
|
US20100009927 |
Anti-Inflammatory and Anti-Allergy Extracts from Nettle
The present invention relates in part to nettle extracts that are useful for treating or preventing seasonal allergies, allergic rhinitis, and other inflammatory conditions. |